Pharmaceuticals and Medical Research (TRBC)

J&J defends itself in trial over baby powder asbestos claims

J&J defends itself in trial over baby powder asbestos claims

Published 15/05/2018

(Reuters) - A trial for a lawsuit alleging that Johnson & Johnson Baby Powder was responsible for the death of a woman due to her [more…]

U.S. to consider expanding Medicare drug price negotiation

U.S. to consider expanding Medicare drug price negotiation

Published 14/05/2018

WASHINGTON/NEW YORK (Reuters) - The Trump administration is considering expanding Medicare’s ability to negotiate the cost of drugs by giving private payers a role in [more…]

WHO says 19 dead, 39 infected so far in Congo Ebola outbreak

WHO says 19 dead, 39 infected so far in Congo Ebola outbreak

Published 14/05/2018

GENEVA (Reuters) - Democratic Republic of Congo reported 39 suspected, probable or confirmed cases of Ebola between April 4 and May 13, including 19 deaths, [more…]

WHO gets approval to use Ebola vaccine in Democratic Republic of Congo

WHO gets approval to use Ebola vaccine in Democratic Republic of Congo

Published 14/05/2018

GENEVA (Reuters) - The World Health Organization has been given the go-ahead by officials in the Democratic Republic of Congo to import and use an [more…]

Roche’s Tecentriq combo wins fast FDA review in race to catch rivals

Roche’s Tecentriq combo wins fast FDA review in race to catch rivals

Published 07/05/2018

ZURICH (Reuters) - Roche’s immunotherapy combination that includes Tecentriq, Avastin and chemotherapy will get an accelerated review by U.S. regulators for use as an initial [more…]

U.S. drug agency suspends Louisiana distributor over opioid sales

U.S. drug agency suspends Louisiana distributor over opioid sales

Published 04/05/2018

WASHINGTON (Reuters) - The U.S. Drug Enforcement Administration said on Friday it had suspended a Louisiana pharmaceutical distributor from selling controlled substances for allegedly selling [more…]

FDA approves Novartis combo therapy for aggressive type of thyroid…

FDA approves Novartis combo therapy for aggressive type of thyroid…

Published 04/05/2018

(Reuters) - The U.S. Food and Drug Administration on Friday approved Novartis AG’s combination therapy to treat an aggressive type of thyroid cancer. The therapy, [more…]

FDA chief questions protections on drug rebates, stocks fall

FDA chief questions protections on drug rebates, stocks fall

Published 04/05/2018

(Reuters) - U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health insurers should remain protected by [more…]

Overactive immune response linked to hair graying

Overactive immune response linked to hair graying

Published 03/05/2018

(Reuters Health) - An overactive immune response, which can occur with viral infections, could result in sudden hair graying, according to research in mice. The [more…]

Discovery of malaria parasite survival genes offers new targets

Discovery of malaria parasite survival genes offers new targets

Published 03/05/2018

LONDON (Reuters) - Scientists have identified the core genes that are essential for the deadliest malaria parasite to survive, revealing new targets for drugs or [more…]